Stay updated on Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.

Latest updates to the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPublication notes now say that publications are automatically filled from PubMed and may or may not be about the study. The Revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the banner about government funding lapse and NIH operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedNo additions or deletions detected; the page content remains unchanged.SummaryDifference0.4%

- Check62 days agoChange Detected- Added a government-operating-status notice and a link to official sources; - Updated software version from v3.1.0 to v3.2.0; - Removed the old version reference.SummaryDifference3%

- Check69 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page is updated to revision v3.0.2 (replacing v3.0.1), and the Back to Top link was removed.SummaryDifference0.2%

Stay in the know with updates to Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.